A detailed history of Game Creek Capital, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Game Creek Capital, LP holds 7,425 shares of LLY stock, worth $7.59 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares
7,425
Previous 2,300 222.83%
Holding current value
$7.59 Million
Previous $1.79 Million 216.13%
% of portfolio
2.14%
Previous 0.81%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$625.65 - $812.69 $3.21 Million - $4.17 Million
5,125 Added 222.83%
7,425 $5.67 Million
Q2 2025

Aug 14, 2025

BUY
$713.71 - $898.95 $1.64 Million - $2.07 Million
2,300 New
2,300 $1.79 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $326,524 - $385,440
-4,400 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $360,536 - $386,716
4,400
4,400 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Game Creek Capital, LP Portfolio

Follow Game Creek Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Creek Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Game Creek Capital, LP with notifications on news.